A detailed history of Fidelis Capital Partners, LLC transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 5,253 shares of IBB stock, worth $724,703. This represents 0.09% of its overall portfolio holdings.

Number of Shares
5,253
Previous 4,844 8.44%
Holding current value
$724,703
Previous $669 Million 11.56%
% of portfolio
0.09%
Previous 0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$135.09 - $149.47 $55,251 - $61,133
409 Added 8.44%
5,253 $747 Million
Q2 2024

Aug 13, 2024

BUY
$124.64 - $139.96 $200,670 - $225,335
1,610 Added 49.78%
4,844 $669 Million
Q1 2024

May 03, 2024

BUY
$132.3 - $140.89 $2,249 - $2,395
17 Added 0.53%
3,234 $444 Million
Q1 2024

May 01, 2024

BUY
$132.3 - $140.89 $425,609 - $453,243
3,217 New
3,217 $1.08 Billion

Others Institutions Holding IBB

About ISHARES BIOTECHNOLOGY ETF


  • Ticker IBB
  • Sector ETFs
  • Industry ETFs
More about IBB
Track This Portfolio

Track Fidelis Capital Partners, LLC Portfolio

Follow Fidelis Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fidelis Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fidelis Capital Partners, LLC with notifications on news.